Open Stage Seminar Oct. 12 (Fri.)  11:00 ~ 11:40


Tomohiro Tokura

Advanced Medical Business Promotion Department, Head Office of Life Science Business, Cell Processing Technology R&D Section

Development of suspension culture system for stem cells

It is expected that regenerative medicine and cell therapy using pluripotent stem cells will be alternative therapies for many patients of orphan diseases.
When considering industrialization of regenerative medicine, it is necessary to develop mass culture system for pluripotent stem cells. In conventional method, cell sources are prepared by manual operation it causes high costs of labor and facility. Furthermore, mass culture methods are attracting attention as tissue engineering technologies improve. We are developing mass culture system for pluripotent stem cells, and we would like to introduce our single-use bioreactor system "Tres-Cuna™".

Window Close